Clinical Diabetes Management for Primary Care Clinicians - June 2024

St. Louis Park, MN US
June 13, 2024 to June 14, 2024

Clinical Diabetes Management for Primary Care Clinicians

Diabetes is a very common and serious disease. New diabetes therapies and technologies are expanding dramatically and evidence-based guidelines are continually changing, making management more challenging. Keeping current with the latest therapies for the management of diabetes and related comorbidities is difficult and time consuming.

Primary care clinicians are increasingly responsible for diabetes management and education. This requires extensive knowledge of the natural history of diabetes and recommended treatment options, as well as the ability to teach people how to successfully manage their disease. Given the complex and diverse nature of diabetes, education on evidence-based practice guidelines and protocols is vital to a clinician’s ability to effectively treat individuals with diabetes.

This program uses lectures and interactive learning activities based on the latest research and clinically proven therapies. With an emphasis on application, this comprehensive program for medical professionals includes practice-based case studies. This program will give providers increased knowledge, skills and confidence, and provide tools to manage this complex chronic disease.

Target Audience

Primary care physicians, nurse practitioners and physician assistants; medical therapy management pharmacists, certified diabetes educators

Learning Objectives

Following this learning activity, participants will be able to:

  • Discuss the underlying defects and natural history of diabetes
  • Evaluate noninsulin diabetes therapies and identify principles for selecting, combining and advancing therapies
  • Initiate insulin therapy based on individual assessment and adjust insulin doses based on blood glucose monitoring pattern management or using continuous glucose monitoring data
  • Develop strategies to improve adherence to diabetes self-management activities such as lifestyle changes and glucose monitoring
  • Outline a systematic approach for screening and managing the complications of diabetes: hypertension, dyslipidemia, renal disease, neuropathy, wound care and sexual function
  • Describe diabetes management in gestational diabetes and type 2 diabetes in pregnancy
  • Discuss evidence-based strategies to address obesity
  • Implement at least two practice changes into patient care
Course summary
Available credit: 
  • 14.75 AAFP Prescribed
  • 14.75 AMA PRA Category 1 Credit™
  • 14.75 Attendance
    This program is designed to meet the Minnesota Board of Nursing’s requirements. It is the responsibility of each nurse to determine if the program meets the criteria for licensure or recertification in their discipline.
  • 14.75 MN Board of Pharmacy
    HealthPartners is approved by the Minnesota State Board of Pharmacy as a provider of continuing pharmaceutical education for Minnesota pharmacists. This program has been approved and is acceptable for 14.75 hours of continuing education credit. The program number assigned to this course is: 2-031-485-060B.
Course opens: 
03/07/2024
Course expires: 
07/14/2024
Event starts: 
06/13/2024 - 8:00am CDT
Event ends: 
06/14/2024 - 4:45pm CDT
Cost:
$575.00
Add to calendar: 
Rating: 
0
Printable Brochure and Agenda

Thursday: Day 1

7:30 am              Registration and light breakfast
8:00 Welcome and announcements
8:15 Diabetes Management Today (includes 15-minute pre-test)
9:15 Medical Nutrition Therapy for Diabetes
9:55 Commonly Asked Nutrition Questions
10:15 Break
10:30 Navigating the Maze of Noninsulin Therapies
Noon Lunch
1:00 pm Use of Continuous Glucose Monitoring in Type 2 Diabetes Management
1:45 Moving the Needle on Insulin Therapy
2:30 Break
2:45 Glucose Pattern Management: Focus on Insulin
3:45 Diabetes Management in Gestational Diabetes and Type 2 Diabetes in Pregnancy 
4:15 How Diabetes Affects Sexual Health
5:00 Adjourn

Friday: Day 2

7:45 amLight breakfast  
8:00Ask the Endocrinologist
9:15Diabetes and the Foot: Neuropathy and Wound Care
9:45Break
10:00Options for the Person with Overweight/Obesity
10:45CVD in Diabetes: Focus HTN and Lipid Management
11:45Lunch
12:30 pmIntegrating CGM into your Practice
2:00Type 2 Diabetes Prevention in Adolescents
2:30Post-Test
2:45Kidney Disease and Diabetes
3:30Adjourn
3:451-hour Optional Case Study Open Forum


Try these routes to get some steps in during the breaks:
Indoor Walking Map
Outdoor Walking Map

Naegele Auditorium - Park Nicollet Clinic & Specialty Center
3800 Park Nicollet Blvd
St. Louis Park, MN 55416
United States
Directions and parking

Take Highway 100 to Excelsior Blvd.; east to Park Nicollet Blvd. (behind McDonalds; across from Miracle Mile Shopping Center); turn left into the clinic campus and follow signs to the free patient and visitor parking ramp or valet. Handicapped parking is available on each level of the ramp and noted surface lots near building entrances. Please park on the upper levels of the ramp to allow priority parking for our patients. A map of the campus can be found here.

The campus consists of three clinic buildings – 3800, 3850 and 3900. Enclosed skyways located on the second level of the parking ramp connect the buildings. 
Follow signs to the 3800 building and elevators. Naegele Auditorium is located on the 7th floor.

Additional parking: If you don’t mind a short walk, there is free parking along Wolfe Park as well as a free ramp at Excelsior & Grand, they are about a 4 minute walk to the 3800 building. A local map can be found here. Check with your hotel to see if they provide free shuttle to our location, several do. Parking on-site can be very limited.

Travel

Nearby Hotels:

Marriott Residency
952-893-9300
Close to MSP Airport and Mall of America
About 20-30 min from conference (varies with traffic)

Homewood Suites
952-544-0495
About 10 min from conference

Holiday Inn
763-545-8300
About 10 min from conference

All of the relevant financial relationships listed for these individuals have been mitigated.

In the past 24 months all industry sponsored research activity that has been disclosed was performed under contract to the non-profit HealthPartners Institute and the International Diabetes Center of which they are employees.

Content Reviewer

Jeremy Springer, MD has no relevant financial relationships to disclose at this time.

Course Director(s)

Gregg Simonson, PhD

has a financial relationship (Grant Or Contract) with Abbott Diabetes Care;.
Faculty/Instructor(s)

Michael Butcher, DO, FACOS, FECSM

has no relevant financial relationships to disclose at this time.

Anders Carlson, MD

has a financial relationship (Other) with Insulet;.
has a financial relationship (Other) with Dexcom;.
has a financial relationship (Other) with Tandem;.
has a financial relationship (Other) with Novo Nordisk;.
has a financial relationship (Other) with Medtronic;.
has a financial relationship (Other) with Eli Lilly;.
has a financial relationship (Other) with Sanofi;.
has a financial relationship (Other) with Mannkind;.

Molly Carlson, MD

has no relevant financial relationships to disclose at this time.

Michael Eastman, DO, MFA

has no relevant financial relationships to disclose at this time.

Tara Ettestad, RDN, LD, CDCES

has a financial relationship (Independent contractor) with Tandem Diabetes;.
has a financial relationship (Grant Or Contract) with Sanofi Aventis Groupe;.
has a financial relationship (Grant Or Contract) with Abbott Diabetes Care;.

Katrina Flaskerud, MS, RDN, LD, CDCES

has no relevant financial relationships to disclose at this time.

Elizabeth Johnson, RDN, LD, CDCES

has a financial relationship (Professional Services) with Abbott;.

Andrew Kummer, MD, MPH

has no relevant financial relationships to disclose at this time.

Janet Lima, MPH, RN, CDCES

has no relevant financial relationships to disclose at this time.

Samar Malaeb

has no relevant financial relationships to disclose at this time.

Thomas Martens, MD

has a financial relationship (Grant Or Contract) with Insulet;.
has a financial relationship (Grant Or Contract) with All industry contracts;.
has a financial relationship (Grant Or Contract) with Medtronic;.
has a financial relationship (Grant Or Contract) with Sanofi;.
has a financial relationship (Grant Or Contract) with Abbott Diabetes Care;.
has a financial relationship (Grant Or Contract) with Lilly;.
has a financial relationship (Grant Or Contract) with Tandem;.
has a financial relationship (Grant Or Contract) with Dexcom;.
has a financial relationship (Grant Or Contract) with Novo Nordisk;.
has a financial relationship (Grant Or Contract) with Dexcom;.

Laura Ross, PA-C

has no relevant financial relationships to disclose at this time.

Betsy Schwartz, MD

has no relevant financial relationships to disclose at this time.

Gregg Simonson, PhD

has a financial relationship (Grant Or Contract) with Abbott Diabetes Care;.

Jennifer Vesely, MD

has no relevant financial relationships to disclose at this time.
Planner(s)

Tara Ettestad, RDN, LD, CDCES

has a financial relationship (Grant Or Contract) with Abbott Diabetes Care;.
has a financial relationship (Independent contractor) with Tandem Diabetes;.
has a financial relationship (Grant Or Contract) with Sanofi Aventis Groupe;.

Thomas Martens, MD

has a financial relationship (Grant Or Contract) with Lilly;.
has a financial relationship (Grant Or Contract) with Tandem;.
has a financial relationship (Grant Or Contract) with Abbott Diabetes Care;.
has a financial relationship (Grant Or Contract) with Novo Nordisk;.
has a financial relationship (Grant Or Contract) with Dexcom;.
has a financial relationship (Grant Or Contract) with Dexcom;.
has a financial relationship (Grant Or Contract) with Insulet;.
has a financial relationship (Grant Or Contract) with All industry contracts;.
has a financial relationship (Grant Or Contract) with Sanofi;.
has a financial relationship (Grant Or Contract) with Medtronic;.

Gregg Simonson, PhD

has a financial relationship (Grant Or Contract) with Abbott Diabetes Care;.
Disclosure link: 
Disclosure and Content Validation

HealthPartners is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

HealthPartners Office of Continuing Medical Education designates this live activity for a maximum of 14.75* AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAFP has reviewed Clinical Diabetes Management - 2024, and deemed it acceptable for AAFP credit. Term of approval is from 06/13/2024 to 10/04/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 14.75* Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
  • 14.75* MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit.

This program has been approved by the Minnesota Board of Pharmacy and is acceptable for 14.75* hours. The program number assigned to this course is 2-031-485-060B .

This program is designed to meet the Minnesota Board of Nursing requirements. It is the responsibility of each participant to determine if the program meets the criteria for licensure or recertification for their discipline.

*14.75 includes an optional 1-hour case study on Friday

Available Credit

  • 14.75 AAFP Prescribed
  • 14.75 AMA PRA Category 1 Credit™
  • 14.75 Attendance
    This program is designed to meet the Minnesota Board of Nursing’s requirements. It is the responsibility of each nurse to determine if the program meets the criteria for licensure or recertification in their discipline.
  • 14.75 MN Board of Pharmacy
    HealthPartners is approved by the Minnesota State Board of Pharmacy as a provider of continuing pharmaceutical education for Minnesota pharmacists. This program has been approved and is acceptable for 14.75 hours of continuing education credit. The program number assigned to this course is: 2-031-485-060B.

Price

Cost:
$575.00
Please login or register to take this course.

For help setting up a new account, reference this tutorial.

Once you are logged in to your account, select your registration type and click Add to Cart to continue.
 

If you are already registered for this program, click Take Course to begin.
 

Please review our Cancellation and Refund Policy.
Cancellations must be received by 5:00 p.m. Central Time on June 5th, 2024. No refunds will be issued after this time. 

Required Hardware/software

PDF Viewer
Chrome or Firefox recommended